| FEGOX | FGDCX | FEGOX / FGDCX | |
| Total Expense Ratio | 1.91 | 1.72 | 111% |
| Annual Report Gross Expense Ratio | 1.91 | 1.72 | 111% |
| Fund Existence | 23 years | 19 years | - |
| Gain YTD | 103.377 | 114.167 | 91% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.95B | 3.41B | 145% |
| Annual Yield % from dividends | 2.71 | 1.31 | 207% |
| Returns for 1 year | 95.08 | 108.30 | 88% |
| Returns for 3 years | 144.56 | 148.98 | 97% |
| Returns for 5 years | 104.35 | 76.54 | 136% |
| Returns for 10 years | 353.32 | 310.45 | 114% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JVAAX | 39.75 | 0.15 | +0.38% |
| JPMorgan Value Advantage A | |||
| EGOCX | 19.78 | 0.07 | +0.36% |
| Allspring Large Cap Core C | |||
| TRPBX | 26.63 | 0.03 | +0.11% |
| T. Rowe Price Spectrum Moderate Allc Inv | |||
| SMUYX | 10.31 | N/A | N/A |
| SEI Multi-Strategy Alternative Y (SIMT) | |||
| LYFIX | 15.51 | N/A | N/A |
| AlphaCentric Life Sciences & Hlthcare I | |||